Search for: "Actavis L" Results 41 - 60 of 61
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2013, 8:18 am by Matthew Lanahan
Muller at Excess of Democracy, while at The Daily Beast, Richard L. [read post]
20 Nov 2012, 6:57 am
Richard observes that these comments are made all the more relevant by the recent Kat-rant over the pathetically short time available for consultation in Actavis v Sanofi, a reference to the CJEU in which, this Kat believes, a good case could be made out for a more generous time allowance given the political and economic significance of the case's outcome. [read post]
14 Mar 2012, 10:00 pm by Laurent Teyssèdre
Plus précisément, il s'agissait de savoir si une combinaison de principes actifs (en l'occurrence l'association valsartan - hydrochlorothiazide) était couverte par un CCP dont l'AMM de référence portait sur un des principes actifs (le valsartan). [read post]
8 Jan 2012, 9:00 pm by Laurent Teyssèdre
La société Actavis commercialise un médicament comprenant le valsartan en association avec de l'hydrochlorothiazide. [read post]
27 Jan 2010, 3:00 am
Aurobindo Pharma Limited (Patentcircle) India/US: Indian pharma sector ‘fares well’ in US disputes (PatLit) India: The woes of the grassroot innovator in the agricultural sector (Spicy IP) South Africa: Biopiracy in Alice – Schwabe Pharamaceuticals wishes to patent method for extracting active ingredient in cough medicine from pelargonium roots (Afro-IP) UK: Okay to split costs where actions are joined, says Court of Appeal: Actavis UK Ltd v Eli Lilly & Co Ltd (PatLit)… [read post]
29 Oct 2009, 3:13 am
L-336006-85, 1986 WL 637507 (N.J. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
28 Sep 2009, 1:31 am
We received a copy of Ford Motor Co. v. [read post]
24 Sep 2009, 5:09 am
We received a copy of Ford Motor Co. v. [read post]
27 Jul 2009, 2:28 am
Now think of the fact that the average body has only five times that amount (5 liters) of blood circulating at any given moment, and you can see just how important it is for a drug manufacturer to get it right the first time.That is because it only takes as little 4.0 ug/L to be in the toxic range. [read post]
8 Oct 2008, 10:13 am
While Aerotel placed a large wedge between the EPO Board of Appeals and English courts, recent cases have been bridging the gap, particularly in the area of obviousness in non-software cases (namely, Conor v Angiotech and Actavis v Merck). [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]